People: Roche Holding AG (ROG.VX)

ROG.VX on Virt-X Level 1

276.00CHF
9:13am EDT
Price Change (% chg)

CHF0.20 (+0.07%)
Prev Close
CHF275.80
Open
CHF276.30
Day's High
CHF276.90
Day's Low
CHF275.30
Volume
551,385
Avg. Vol
1,016,799
52-wk High
CHF276.90
52-wk Low
CHF231.20

Search Stocks

O'Day, Daniel 

Brief Biography

Mr. Daniel O'Day has been Member of the Corporate Executive Committee, Chief Operating Officer Division Roche Pharmaceuticals at Roche Holding AG since Janaury 1, 2010. From 1987 to 1995 he held various commercial and sales roles at Roche Pharma in the United States, becoming Director of Human Resources in 1995. From 1996 he was Director of Product Marketing at Roche Pharma in the United States. From 1998 he worked for Roche Pharma HQ in Switzerland. From 2001 he acted at Roche Pharma in Japan as Head of Corporate Planning. In 2003 he became General Manager at Roche Pharma in Denmark. Since 2006, he has been President and Chief Executive Officer of Roche Molecular Diagnostics in the United States. He received a Bachelor of Science in Biology from the Georgetown University, Washington DC in 1986 and an MBA from Columbia University, New York in 1997.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
4,500,000 -- -- 4,500,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Severin Schwan

13,212,000

Fritz Gerber

--

Franz Humer

9,158,000

Andre Hoffmann

400,000

Alan Hippe

4,000,000

Stephan Feldhaus

--
As Of 30 Dec 2013
Search Stocks